Results 121 to 130 of about 3,390,641 (355)
Role of Chlamydia pneumoniae and Mycoplasma pneumoniae as Causative Agents of Community-Acquired Pneumonia in Hospitalised Children and Adolescents [PDF]
The aim of the study presented here was to determine the prevalence of Chlamydia pneumoniae versus Mycoplasma pneumoniae infections in paediatric patients with community-acquired pneumonia.
Abele-Horn, M. +4 more
core
ARID1A, a SWI/SNF complex component, is frequently mutated in colorectal cancer (CRC). CRC with ARID1A/TP53 concurrent mutations shows marked sensitivity to WEE1 inhibition. ARID1A loss induces R‐loop‐mediated replication stress, impairs ATF3 transcription, and amplifies WEE1i‐induced DNA damage, suggesting a promising therapeutic vulnerability ...
Chi Zhang +17 more
wiley +1 more source
Chlamydia trachomatis and mycoplasma infections in tubal pregnancy. [PDF]
Liu Y +12 more
europepmc +1 more source
Ongoing epidemic of Mycoplasma pneumoniae infection in Jerusalem, Israel, 2010 to 2012 [PDF]
Ran Nir‐Paz +4 more
openalex +1 more source
Development of a relative quantification real-time PCR assay for infection status investigation of Mycoplasma hyopneumoniae and Mycoplasma hyorhinis in nursery and finished pigs [PDF]
Wei‐Hao Lin +5 more
openalex +1 more source
Cryopreserved lung‐humanized mice overcome the dependency to fresh tissues and permit head‐to‐head profiling of all four human common cold coronaviruses versus SARS‐CoV‐2 infection; the model validates Paxlovid efficacy against HKU1 and, when coupled with human immune‐system engraftment, enables interrogation of lung‐resident human immunity and HKU1 ...
Chunyu Cheng +9 more
wiley +1 more source
Quantification of the spread of Mycoplasma hyopneumoniae in nursery pigs using transmission experiments [PDF]
de Kruif, Aart +5 more
core +1 more source
In this work, we showcased two significant scientific advances in (i) developing a portable biosensor technology for rapid decentralized prostate cancer urinary biomarker testing and reporting, with superior performance to current clinical testing practice; and (ii) proposing a clinical validation framework (for our biosensor development) which can be ...
Kevin M. Koo +14 more
wiley +1 more source
Surfactant Dysfunction in SP-A −/− and iNOS −/− Mice with Mycoplasma Infection
Judy M. Hickman‐Davis +6 more
openalex +1 more source
By integrating a convergent molecular platform strategy, this study designed a novel dual‐target C5 to combat multidrug‐resistant Gram‐negative bacteria. C5 synergistically enhances antibiotic efficacy by inhibiting efflux pumps and increasing bacterial membrane permeability.
Jiale Dong +11 more
wiley +1 more source

